An overall decrease in C-reactive protein, TNF-α and IL-6 and an increase in adiponectin levels, indicated an improvement in the inflammatory and possibly the oxidative status of NAFLD patients [61]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.